The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers
dc.contributor.author | Lyratzopoulos, G | |
dc.contributor.author | Saunders, CL | |
dc.contributor.author | Abel, GA | |
dc.contributor.author | McPhail, S | |
dc.contributor.author | Neal, RD | |
dc.contributor.author | Wardle, J | |
dc.contributor.author | Rubin, GP | |
dc.date.accessioned | 2019-02-08T10:55:09Z | |
dc.date.issued | 2015-03-31 | |
dc.description.abstract | BACKGROUND: Appreciating variation in the length of pre- or post-presentation diagnostic intervals can help prioritise early diagnosis interventions with either a community or a primary care focus.METHODS: We analysed data from the first English National Audit of Cancer Diagnosis in Primary Care on 10 953 patients with any of 28 cancers. We calculated summary statistics for the length of the patient and the primary care interval and their ratio, by cancer site.RESULTS: Interval lengths varied greatly by cancer. Laryngeal and oropharyngeal cancers had the longest median patient intervals, whereas renal and bladder cancer had the shortest (34.5 and 30 compared with 3 and 2 days, respectively). Multiple myeloma and gallbladder cancer had the longest median primary care intervals, and melanoma and breast cancer had the shortest (20.5 and 20 compared with 0 and 0 days, respectively). Mean patient intervals were longer than primary care intervals for most (18 of 28) cancers, and notably so (two- to five-fold greater) for 10 cancers (breast, melanoma, testicular, vulval, cervical, endometrial, oropharyngeal, laryngeal, ovarian and thyroid).CONCLUSIONS: The findings support the continuing development and evaluation of public health interventions aimed at shortening patient intervals, particularly for cancers with long patient interval and/or high patient interval over primary care interval ratio. | en_GB |
dc.description.sponsorship | National Institute for Health Research (NIHR) | en_GB |
dc.description.sponsorship | Cancer Research UK | en_GB |
dc.description.sponsorship | Public Health Wales | en_GB |
dc.description.sponsorship | Betsi Cadwaladr University Health Board | en_GB |
dc.identifier.citation | Vol. 112, pp. S35 - S40 | en_GB |
dc.identifier.doi | 10.1038/bjc.2015.40 | |
dc.identifier.grantnumber | PDF-2011-04-047 | en_GB |
dc.identifier.grantnumber | A18180 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/35839 | |
dc.language.iso | en | en_GB |
dc.publisher | Springer Nature / Cancer Research UK | en_GB |
dc.rights | © 2015 Cancer Research UK. This work isl icensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ | en_GB |
dc.title | The relative length of the patient and the primary care interval in patients with 28 common and rarer cancers | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2019-02-08T10:55:09Z | |
dc.identifier.issn | 0007-0920 | |
dc.description | This is the final version. Available from the publisher via the DOI in this record. | en_GB |
dc.identifier.journal | British Journal of Cancer | en_GB |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_GB |
pubs.euro-pubmed-id | MED:25734380 | |
dcterms.dateAccepted | 2015-03-31 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2015-03-31 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2019-02-08T10:49:41Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2019-02-08T10:55:12Z | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © 2015 Cancer Research UK. This work isl icensed under the Creative Commons
Attribution 4.0 International License. To view a
copy of this license, visit http://creativecommons.org/licenses/by/4.0/